Cargando…

Integrated analysis of genome-wide DNA methylation and cancer-associated fibroblasts identified prognostic biomarkers and immune checkpoint blockade in lower grade gliomas

BACKGROUND: Cancer-associated fibroblasts (CAFs) are vital components of prominent cellular components in lower-grade gliomas (LGGs) that contribute to LGGs’ progression, treatment resistance, and immunosuppression. Epigenetic modification and immunity have significant implications for tumorigenesis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Jiawei, Wang, Fang, Gao, Xin, Zhao, Hongtao, Zhang, Jiheng, Wang, Nan, Liu, Zhihui, Yan, Xiuwei, Jin, Jiaqi, Ba, Yixu, Ma, Shuai, Du, Jianyang, Ji, Hang, Hu, Shaoshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885112/ https://www.ncbi.nlm.nih.gov/pubmed/36727078 http://dx.doi.org/10.3389/fonc.2022.977251

Ejemplares similares

5-Methylcytosine Related LncRNAs Reveal Immune Characteristics, Predict Prognosis and Oncology Treatment Outcome in Lower-Grade Gliomas
por: Zhang, Jiheng, et al.
Publicado: (2022)

A cuproptosis-related lncRNAs signature for prognosis, chemotherapy, and immune checkpoint blockade therapy of low-grade glioma
por: Yan, Xiuwei, et al.
Publicado: (2022)

Characterization of the Ferroptosis-Related Genes for Prognosis and Immune Infiltration in Low-Grade Glioma
por: Yan, Xiuwei, et al.
Publicado: (2022)

Multiomics Data Analysis and Identification of Immune-Related Prognostic Signatures With Potential Implications in Prognosis and Immune Checkpoint Blockade Therapy of Glioblastoma
por: Ma, Shuai, et al.
Publicado: (2022)

Identification of EMT-Related Genes and Prognostic Signature With Significant Implications on Biological Properties and Oncology Treatment of Lower Grade Gliomas
por: Wu, Jiasheng, et al.
Publicado: (2022)

Machine learning-based screening of an epithelial-mesenchymal transition-related long non-coding RNA signature reveals lower-grade glioma prognosis and the tumor microenvironment and predicts antitumor therapy response
por: Wang, Nan, et al.
Publicado: (2022)

IGFBPs were associated with stemness, inflammation, extracellular matrix remodeling and poor prognosis of low-grade glioma
por: Liu, Zhihui, et al.
Publicado: (2022)

Stromal protein CCN family contributes to the poor prognosis in lower-grade gioma by modulating immunity, matrix, stemness, and metabolism
por: Liu, Zhihui, et al.
Publicado: (2022)

Recognition of Tumor-Associated Antigens and Immune Subtypes in Glioma for mRNA Vaccine Development
por: Ma, Shuai, et al.
Publicado: (2021)

Expression of intra-tumoral necrosis-associated cytokine pattern correlated with prognosis and immune status in glioma
por: Zhao, Hongtao, et al.
Publicado: (2023)

Novel Immune-Related Gene-Based Signature Characterizing an Inflamed Microenvironment Predicts Prognosis and Radiotherapy Efficacy in Glioblastoma
por: Ji, Hang, et al.
Publicado: (2022)

Using mixed reality technique combines multimodal imaging signatures to adjuvant glioma photodynamic therapy
por: Dong, Jiawei, et al.
Publicado: (2023)

Integrated genomic, transcriptomic, and epigenetic analyses identify a leukotriene synthesis-related M2 macrophage gene signature that predicts prognosis and treatment vulnerability in gliomas
por: Ji, Hang, et al.
Publicado: (2022)

Ferroptosis-Related Gene Contributes to Immunity, Stemness and Predicts Prognosis in Glioblastoma Multiforme
por: Dong, Jiawei, et al.
Publicado: (2022)

Pituitary adenoma secondary to primary hypothyroidism: Two case reports
por: Du, Jianyang, et al.
Publicado: (2020)

Extended Application of Genomic Selection to Screen Multi-Omics Data for the Development of Novel Pyroptosis-Immune Signatures and Predicting Immunotherapy of Glioma
por: Ma, Shuai, et al.
Publicado: (2022)

Identification of Prognostic Model and Biomarkers for Cancer Stem Cell Characteristics in Glioblastoma by Network Analysis of Multi-Omics Data and Stemness Indices
por: Du, Jianyang, et al.
Publicado: (2020)

CCR5 as a Prognostic Factor in Lower-Grade Glioma is Involved in the Remodeling of the Tumor Microenvironment
por: Wang, Fang, et al.
Publicado: (2022)

Rapid progression of subcutaneous glioblastoma: A case report and literature review
por: Wang, Fang, et al.
Publicado: (2023)

Construction of Interferon-Gamma-Related Gene Signature to Characterize the Immune-Inflamed Phenotype of Glioblastoma and Predict Prognosis, Efficacy of Immunotherapy and Radiotherapy
por: Ji, Hang, et al.
Publicado: (2021)

Malignant Evaluation and Clinical Prognostic Values of m6A RNA Methylation Regulators in Glioblastoma
por: Du, Jianyang, et al.
Publicado: (2020)

A Novel Four-Gene Signature Associated With Immune Checkpoint for Predicting Prognosis in Lower-Grade Glioma
por: Xiao, Youchao, et al.
Publicado: (2020)

Immune-Checkpoint Blockade and Active Immunotherapy for Glioma
por: Ahn, Brian J., et al.
Publicado: (2013)

PODNL1 Methylation Serves as a Prognostic Biomarker and Associates with Immune Cell Infiltration and Immune Checkpoint Blockade Response in Lower-Grade Glioma
por: Noor, Humaira, et al.
Publicado: (2021)

Lower Grade Gliomas
por: Youssef, Gilbert, et al.
Publicado: (2020)

Systematic analysis of the necroptosis index in pan-cancer and classification in discriminating the prognosis and immunotherapy responses of 1716 glioma patients
por: Ma, Shuai, et al.
Publicado: (2023)

Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas
por: Aslan, Katrin, et al.
Publicado: (2020)

C5aR1 blockade reshapes immunosuppressive tumor microenvironment and synergizes with immune checkpoint blockade therapy in high-grade serous ovarian cancer
por: Zhang, Chen, et al.
Publicado: (2023)

A Novel Multi-Omics Analysis Model for Diagnosis and Survival Prediction of Lower-Grade Glioma Patients
por: Wu, Wei, et al.
Publicado: (2022)

A 2-Gene Signature Related to Interferon-Gamma Predicts Prognosis and Responsiveness to Immune Checkpoint Blockade of Glioma
por: Li, Yongzhe, et al.
Publicado: (2022)

Resilience in Lower Grade Glioma Patients
por: Fröhlich, Ellen, et al.
Publicado: (2022)

Preclinical modeling of lower-grade gliomas
por: Tang, Lilly W., et al.
Publicado: (2023)

Fibroblast Activation Protein-α-Positive Fibroblasts Promote Gastric Cancer Progression and Resistance to Immune Checkpoint Blockade
por: Wen, Xuyang, et al.
Publicado: (2017)

FABP5 enhances malignancies of lower‐grade gliomas via canonical activation of NF‐κB signaling
por: Wang, Yichang, et al.
Publicado: (2021)

Neutrophil extracellular traps contribute to coagulopathy after traumatic brain injury
por: Jin, Jiaqi, et al.
Publicado: (2023)

Recent Advances in Glioma Therapy: Combining Vascular Normalization and Immune Checkpoint Blockade
por: Ho, Rachel L. Y., et al.
Publicado: (2021)

Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients
por: Zhu, Hua, et al.
Publicado: (2022)

CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer
por: Yang, Moran, et al.
Publicado: (2021)

High Grade Dermatologic Adverse Events Associated With Immune Checkpoint Blockade for Cancer
por: Kuo, Alyce M., et al.
Publicado: (2022)

Genome‐wide methylomic analyses identify prognostic epigenetic signature in lower grade glioma
por: Guo, Wenna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k915krbrg15j2ngmnqsnfiaapg